Radiopharmaceutical theragnostic is a medical technology that combines diagnostic imaging and therapeutic capabilities using radiopharmaceutical agents. The radiopharmaceutical theragnostic market is driven by the increasing incidence of cancer and the growing demand for personalized medicine.

Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis):

The Global Radiopharmaceutical Theragnostic Market was valued at USD 4.8 billion in 2021 and is expected to reach USD 14.3 billion by 2030, growing at a CAGR of 14.3% from 2022 to 2030. The increasing incidence of cancer and the growing demand for personalized medicine are the primary drivers of market growth.

Key Players Influencing the Radiopharmaceutical Theragnostic Market: Advanced Accelerator Applications, A Novartis Company, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical Imaging Inc., NanoMab, NuView Life Sciences, PentixaPharm GmbH, Precirix, RadioMedix, RayzeBio, Telix Pharmaceuticals Limited, Theragnostics Ltd and Vect-Horus.

Speak to our analyst in case of queries before buying this report:

One of the primary drivers of the radiopharmaceutical theragnostic market is the increasing incidence of cancer. Cancer is a leading cause of death worldwide, and the incidence of cancer is increasing due to factors such as aging populations, lifestyle changes, and environmental factors. Radiopharmaceutical theragnostic is a promising technology for cancer diagnosis and treatment, enabling personalized medicine and improving patient outcomes. Another driver of the radiopharmaceutical theragnostic market is the growing demand for personalized medicine. Personalized medicine involves tailoring medical treatment to an individual’s unique genetic, environmental, and lifestyle factors. Radiopharmaceutical theragnostic enables personalized medicine by allowing physicians to diagnose and treat patients based on their individual characteristics and needs.

One of the primary restraints of the radiopharmaceutical theragnostic market is the high cost of radiopharmaceutical agents. Radiopharmaceutical agents are expensive to produce and require specialized facilities and expertise. The high cost of radiopharmaceutical agents may limit the adoption of radiopharmaceutical theragnostic in some healthcare settings. Another potential restraint is the regulatory hurdles associated with radiopharmaceutical theragnostic. Radiopharmaceutical theragnostic involves the use of radioactive materials, which are subject to strict regulations to ensure patient safety. The regulatory process can be complex and time-consuming, which may limit the adoption of radiopharmaceutical theragnostic.

Request discount on this premium report:

Our 420+ Pages Report titled, Radiopharmaceutical Theragnostic Market will include extensive information on the following pointers:

  • Global market size and forecast values (2015 – 2030), in terms of revenue (US$ Million) and volume (Kilotons) by segments/sub-segments
  • Split of the market revenue (US$ Million) and Volume (Kilotons) into all the relevant segments & sub-segments across all major regions/countries.
  • Years Considered (2015 – 2030)
    • (Historic Years: 2015 – 2020
    • Base Year: 2021
    • Forecast Years: 2022 – 2030)
  • Market determinants and Influencing Factors
  • Market Dynamics (Drivers, Restraints, Opportunities and Trends)
  • Analysis on Impact of Covid-19 on Global Radiopharmaceutical Theragnostic Market
  • Macro-Economic and Micro-Economic Indicators
  • Porter’s Five Forces Analysis
  • Regulatory Landscape
  • PESTEL Analysis
  • Competitive Benchmarking: Global Presence and Growth Strategies
    • (Mergers and Acquisitions
    • Product Launches
    • Investments Trends
    • R&D Initiatives)
  • Market Share Analysis, 2021
  • Detailed profiles of major market participants operating in the market, encompassing information pertaining to Company Details, Company Overview, Product Offerings, Key Developments, Financial Analysis, SWOT Analysis and Business Strategies
  • Region specific report, including North America, Europe, Asia Pacific, Middle East & Africa and Latin America, can also be provided.
  • The reports can be provided in different languages including German, Korean, Arabic, Russian, French, Japanese, Spanish, Chinese and other languages.

Purchase the latest in-depth Global Radiopharmaceutical Theragnostic Market Report @

Radiopharmaceutical Theragnostic Market Segmentation:

By Clinical Trial Phase

  • Phase I
  • Phase II
  • Phase III

By Application

  • Thyroid cancer
  • Brain cancer
  • Lymphoma
  • Others

By Route of Administration

  • Oral
  • Intravenous
  • Interstitial

By End-Users

  • Hospitals and Clinics
  • Pharmaceutical Companies
  • Research Centers
  • Others

Request for customization to meet your precise research requirements:

We appreciate your reading the article in its entirety. If you would like to know more about the Radiopharmaceutical Theragnostic market, looking for customization, contact us. To achieve a full market reach of Radiopharmaceutical Theragnostic, or explore more about opportunities reach our research analyst. Our team is available 24/7 to assist and support our customers through reliable research.

View our exclusive press releases on Industry Global News24 –

About Us:

Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

Contact Us:

Contact Name: Shreyas Tanna

Company: Absolute Markets Insights

Email Id:

Phone: IN +91-7400-24-24-24, US +1-510-420-1213


Leave a Reply

Your email address will not be published. Required fields are marked *